Marpai, Inc. (MRAI) company profile
Close on Oct 19, 2026Market cap $82.24MP/E –Yield –
About Marpai
Services-Misc Health & Allied Services, NEC, SIC 8090
Marpai, Inc. is a healthcare technology platform company operating subsidiaries that provide third-party administrator and pharmacy benefit management services. The business serves self-insured employers who directly fund employee healthcare programs, with a client base primarily comprising small and medium-sized enterprises as well as local government entities. Its activities span three main revenue streams: health plan administration, in-house ancillary offerings, and third-party vendor services. These solutions include custom benefit plan design, claims adjudication, clinical care navigation, out-of-network claims repricing, specialty drug savings, and comprehensive pharmacy benefit management.
The company focuses its operations on the self-funded healthcare sector across the United States and maintains an Israeli operating subsidiary known as EYME Technologies, Ltd. As of December 31, 2025, Marpai engaged a workforce of 107 full-time employees. The company maintains its principal executive offices and headquarters in Tampa, Florida.
Summary of the business section of Marpai's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Marpai, Inc.
- Headquarters
- Tampa, FL
- Address
- 615 Channelside Drive, Suite 207 33602
- Phone
- (646) 303-3483
- Website
- marpaihealth.com
- Employees
- 107, Dec 31, 2025
- Industry
- Services-Misc Health & Allied Services, NEC
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- UHY LLP, Melville, New York
Stock & identifiers
- Ticker
- MRAI
- Exchange
- OTC
- IPO date
- Oct 28, 2021
- Shares outstanding
- 27M, Aug 13, 2026
- Public float
- $9.75M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-4 reverse, Jun 29, 2023
- SEC CIK
- 1844392
- CUSIP
- 571354109
- ISIN
- US5713541093
- FIGI
- BBG011WQW2R4
- Share class FIGI
- BBG011WQW3M7
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Damien Lamendola | Chief Executive Officer, Director | 2,581,674 |
| Steve Andrew Johnson | Chief Financial Officer | 1,024,192 |
| Dallas Scrip | Chief Operating Officer | 400,000 |
| John Paul Powers | President | 410,000 |
| Colleen DiClaudio | Director | 267,500 |
| Sagiv Shiv | Director | 613,667 |
| Robert M. Pons | Director | 484,200 |
| Jennifer Rosario Calabrese | Director | 225,000 |
| Yaron Eitan | Director | 1,224,073 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $1.21M | $1.16M | $1.26M | $19 | – |
| FY2024 | $362.00K | $712.00K | $514.00K | $25 | – |
| FY2023 | $292.00K | $288.00K | $2.29M | $53 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2024
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Total | vs. prior year |
|---|---|---|---|---|
| Damien Lamendola Chief Executive Officer and Director | – | $362 | $362 | – |
| Steve Johnson Chief Financial Officer | $39 | $211 | $250 | – |
| John Powers President and Chief Operating Officer | $150 | $78 | $228 | – |
| Gonen Antebi Chief Operating Officer | $36 | – | $36 | -91% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Oct 28, 2021
- Offer price
- $4.00
- Securities offered
- 6,250,000
- Gross proceeds
- $25.00M
- Exchange
- Nasdaq
- First trading day
- Oct 27, 2021
- First-day close
- $4.75+18.8%
- Lock-up ends (est.)
- Apr 25, 2022
“The initial public offering price of our shares is $4.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“we had a total of 107 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jun 3, 2024 | Delisting | Notice of delisting from exchange (Form 25) |
| May 24, 2024 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Nov 29, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Oct 6, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jun 2, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 13, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jan 10, 2023 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Nov 1, 2022 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Dec 9, 2021 | Late filing | Notification of late filing |
| Oct 28, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 13, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?